Ratings by BTIG (Robert Hazlett)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
5/27/2021 Compass Pathways CMPS New Coverage Buy
(N/A)
34.37
(34.95)
1.69% Details
5/24/2021 Verastem VSTM Upgrade Buy
(Neutral)
3.19
(4.28)
34.17% Details
4/16/2021 Tracon Pharmaceuticals TCON Upgrade Buy
(Neutral)
7.81
(6.38)
-18.31% Details
2/24/2021 MannKind MNKD Maintain Buy
(N/A)
 
 
  Details
2/2/2021 Matinas BioPharma Holdings Inc. MTNB Maintain Buy
(N/A)
 
 
  Details
2/2/2021 Prothena Corp PRTA Upgrade Buy
(Neutral)
11.00
(45.33)
312.09% Details
12/29/2020 MannKind MNKD Maintain Buy
(N/A)
 
 
  Details
11/2/2020 Intra-Cellular Therapies ITCI Maintain Buy
(N/A)
 
 
  Details
9/9/2020 Intra-Cellular Therapies ITCI Maintain Buy
(N/A)
 
 
  Details
9/4/2020 Akebia Therapeutics AKBA Maintain Buy
(N/A)
 
 
  Details
5/26/2020 Lyra Therapeutics LYRA New Coverage Buy
(N/A)
14.43
(8.08)
-44.01% Details
5/6/2020 Akebia Therapeutics AKBA Maintain Buy
(N/A)
 
 
  Details
4/2/2020 Eiger BioPharma EIGR Maintain Buy
(N/A)
 
 
  Details
3/27/2020 Zosano Pharma ZSAN Maintain Buy
(N/A)
 
 
  Details
3/3/2020 Intra-Cellular Therapies ITCI Maintain Buy
(N/A)
 
 
  Details
2/26/2020 MannKind MNKD Maintain Buy
(N/A)
 
 
  Details
11/1/2019 Paratek Pharmaceuticals PRTK Maintain Sell
(N/A)
 
 
  Details
6/20/2019 Verastem VSTM Downgrade Neutral
(Buy)
1.90
(3.19)
67.89% Details
6/14/2019 Nektar Therapeutics NKTR Maintain Buy
(N/A)
 
 
  Details
5/17/2019 Matinas BioPharma Holdings Inc. MTNB New Coverage Buy
(N/A)
0.92
(0.79)
-14.13% Details
5/14/2019 MannKind MNKD New Coverage Buy
(N/A)
1.25
(4.46)
256.8% Details
5/10/2019 Verastem VSTM Maintain Buy
(N/A)
 
 
  Details
4/12/2019 Tracon Pharmaceuticals TCON Downgrade Neutral
(Buy)
1.30
(6.38)
390.77% Details
2/21/2019 Zosano Pharma ZSAN Maintain Buy
(N/A)
 
 
  Details
2/12/2019 Nektar Therapeutics NKTR Maintain Buy
(N/A)
 
 
  Details
1/8/2019 Axsome Therapeutics AXSM Maintain Buy
(N/A)
 
 
  Details
12/26/2018 Tracon Pharmaceuticals TCON Maintain Buy
(N/A)
 
 
  Details
12/21/2018 Forty Seven Inc. FTSV New Coverage Buy
(N/A)
17.27
(95.51)
453.04% Details
12/19/2018 Eiger BioPharma EIGR Maintain Buy
(N/A)
 
 
  Details
9/26/2018 Zosano Pharma ZSAN Maintain Buy
(N/A)
 
 
  Details
9/25/2018 Verastem VSTM Maintain Buy
(N/A)
 
 
  Details